What are our options for funding a phase 3 trial internally? This would require five or ten million dollars minimum on top of the ulcerative colitis study and Kevetrin trial.
As of the last 10Q, there was just shy of a million in cash available. All of that and more is spoken for by salaries, lease, etc.
Is there another funding vehicle I am missing?
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links